Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 8Bile Duct Neoplasms 4Pancreatic Neoplasms 3Liver Neoplasms 3Colorectal Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Esophageal Neoplasms 2Barrett Esophagus 2Skin Neoplasms 1Rectal Neoplasms 1Photosensitivity Disorders 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms by Site 1Klatskin Tumor 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Digestive System Diseases 1Constriction, Pathologic 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Biliary Tract Diseases 1Bile Duct Diseases 1Adenocarcinoma 1

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Photochemotherapy × Gastrointestinal × Clear all
NCT01522677 2016-12-01

A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer

University of California, Irvine

Phase 1/2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Photosensitivity Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡